Atlas

Form 483

Community Blood Center of Greater Kansas City, an Operating Division of New York Blood Center, Inc. Form 483, 2012-01-30

FDA issued a Form 483 to Community Blood Center of Greater Kansas City, an Operating Division of New York Blood Center, Inc. on 2012-01-30 with 1 public-safe observation.

483· Form 483 issued1 observation

Community Blood Center of Greater Kansas City, an Operating Division of New York Blood Center, Inc. · Topeka, United States · Issued January 30, 2012

Overview

  • 1 public-safe observation is available for this inspection.
  • 1 structured CFR citation is represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

30 Jan 2012
21 CFR 606.20(b)

Qualifications of responsible personnel

Cited by Carmen Y Fisher

Inspected site

CBCommunity Blood Center of Greater Kansas City, an Operating Division of New York Blood Center, Inc.Topeka, United States

Inspection team

CYCarmen Y Fisher

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 606.20(b)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 1 observation

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere